Liver receptor homolog-1: structures, related diseases, and drug discovery

Tong Wu1,2, Zhi-Fang Lu1,2, Hao-Nan Yu2

  • 1Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.

PubMed

Insights

Liver receptor homolog-1 (LRH-1) is a key transcription factor involved in metabolism and immunity. Research shows synthetic ligands can modulate LRH-1, making it a promising drug target for diseases like cancer and inflammation.

Area of Science:

  • Molecular biology
  • Endocrinology
  • Drug discovery

Background:

  • Liver receptor homolog-1 (LRH-1) is a nuclear receptor superfamily member.
  • It functions as a ligand-regulated transcription factor with roles in metabolism, development, and immunity.
  • LRH-1 is considered an 'orphan' receptor due to ligand ambiguity.

Purpose of the Study:

  • To review the structural and functional aspects of LRH-1.
  • To explore diseases associated with LRH-1.
  • To summarize advancements in therapeutic ligand development for LRH-1.

Main Methods:

  • Literature review of structural biology studies.
  • Analysis of functional assays and disease association studies.
  • Survey of recent developments in synthetic ligand research for LRH-1.

Main Results:

  • LRH-1's structure provides a basis for understanding its function.
  • Dysregulation of LRH-1 is linked to various diseases, including metabolic disorders, inflammation, and cancer.
  • Synthetic ligands demonstrate LRH-1's potential as a therapeutic target.

Conclusions:

  • LRH-1 is a significant target for therapeutic intervention.
  • Further research into LRH-1 ligands could lead to novel treatments.
  • Targeting LRH-1 offers potential for managing complex diseases.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.9K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
710
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K